©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The N Terminus of Antizyme Promotes Degradation of Heterologous Proteins (*)

(Received for publication, June 27, 1995; and in revised form, October 19, 1995)

Xianqiang Li (1) Barbara Stebbins (1) Laura Hoffman (3) Greg Pratt (3) Martin Rechsteiner (3) Philip Coffino (1) (2)

From the  (1)Department of Microbiology and Immunology and (2)Department of Medicine, University of California, San Francisco, California 94143 and (3)Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah 84132

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Regulated degradation of ornithine decarboxylase (ODC) is mediated by its association with the inducible protein antizyme. The N terminus of antizyme (NAZ), although unneeded for the interaction with ODC, must be present to induce degradation. We report here that covalently grafting NAZ to ODC confers lability that normally results from the non-covalent association of native antizyme and ODC. To determine whether NAZ could act similarly as a modular functional domain when grafted to other proteins, we fused it to a region of cyclin B (amino acids 13-90) capable of undergoing degradation or to cyclin B (amino acids 13-59), which is not subject to degradation. The association with NAZ made both NAZ-cyclin B and NAZ-cyclin B unstable. Furthermore, NAZ and cyclin B 13-59 were together able to induce in vitro degradation of Trypanosoma brucei ODC, a stable protein. The ODC-antizyme complex bound to the 26 S protease but not the 20 S proteasome, consistent with the observation that ODC degradation is mediated by the 26 S protease. The association was shown to be independent of NAZ, suggesting that NAZ does not act as a recognition signal.


INTRODUCTION

Cellular polyamines are essential for cells to grow and proliferate. Ornithine decarboxylase (ODC), (^1)the key enzyme in the biosynthesis of the polyamines, is highly regulated. Its activity is dramatically increased by stimulating cell growth and decreased by excess polyamines. Feedback regulation of ODC activity by polyamines occurs via induction of the protein antizyme(1, 2, 3, 4, 5) . Antizyme binds to ODC, inhibits its activity, and accelerates its degradation. The determinants within each protein needed for their association have been identified; one element is near the N terminus of ODC(6) , and the other element is the C-terminal half of antizyme(7) . Besides regions that bring the two proteins together, two additional elements are necessary for antizyme-dependent degradation to occur. Both the C-terminal degradation domain of ODC (8) and the N terminus of antizyme are required for proteolysis of ODC. The C terminus of ODC has been characterized as a degradation domain that is sufficient for polyamine-independent basal degradation(8, 9) . Deletion forms of antizyme devoid of the N-terminal half still interact with ODC, but accelerated ODC degradation can be directed only by molecules in which an antizyme N-terminal region is also present(7) .

ODC, like other short-lived proteins, is degraded by the 26 S protease in an ATP-dependent manner. Ubiquitination is a modification that triggers proteolysis of many short-lived proteins (10, 11, 12, 13) , but ODC does not utilize this mechanism. Instead, regulated degradation of ODC requires association with antizyme(14, 15, 16) . The means by which the N terminus of antizyme (NAZ) acts in place of ubiquitin for ODC degradation is unclear. It might function as a signal domain to promote recognition by the 26 S protease or as an activation domain to stimulate degradation. Here we report that AZ contains a module that can be grafted to other proteins to make them labile. We show also that the association of the ODCbulletAZ complex with 26 S protease is independent of NAZ.


MATERIALS AND METHODS

Recombinant DNA Constructs

Recombinant DNAs used for the expression of fusion proteins by in vitro transcription and translation were made as follows. The DNA sequence encoding each constituent protein fragment to be expressed was copied by PCR, using oligonucleotides that incorporated a common restriction endonuclease recognition site at the point of fusion. The PCR fragments encoding the protein regions to be fused were digested with the common restriction enzyme, ligated, and reamplified using the distal 5`- and 3`-oligonucleotides. The 5`-oligonucleotide used to copy the N-terminal element of each fusion contained a T7 RNA polymerase recognition site placed upstream of the translation initiation AUG codon. The resultant PCR product after the second round of amplification thus contained at the 5`-end a T7 RNA polymerase recognition site, followed by an open reading frame encoding the fusion protein. Plasmids encoding sea urchin cyclin B were kindly provided by A. W. Murray (University of California, San Francisco). The rat antizyme gt11 partial cDNA clone Z1 (4) was obtained from S. Hayashi (Jekei University, Tokyo). Z1 has a 212-amino acid open reading frame(5) . We use here a numbering convention that specifies the start of this reading frame to be amino acid 1 of AZ. The sources and sequences of mouse ODC (MODC) and Trypanosoma brucei ODC (TbODC) were as described previously (6, 7, 8) . To fuse the 1-97 N-terminal amino acids of antizyme (NAZ) to various proteins, Z1 DNA was amplified by PCR using a 3`-oligonucleotide with a HindIII site. Similarly using PCR, a HindIII site was introduced at the 5`-ends of MODC, TbODC, Tb376M, Tb422M, and cyclin B amino acids 13-90. PCR-amplified fragments were digested or partially digested with HindIII and ligated to make NAZ-MODC, NAZ-Tb-ODC, NAZ-Tb376M, NAZ-Tb422M, and NAZ-cyclin B 13-90. To make the C-terminal deletion NAZ-cyclin B 13-90, sequence changes were incorporated into the 3`-oligonucleotides, which created translation stop codons immediately after cyclin B amino acid 59. CAZ-MODC was made using a similar strategy by ligating AZ cDNA encoding amino acids 106-212 and mouse ODC cDNA with a HindIII linker. To make fusion proteins of TbODC coupled to the degradation domain of p53, DNA was also amplified by PCR using oligonucleotides that contained a BamHI site at the TbODC 3`-end and at the 5`-end of the p53 degradation domain (amino acids 100-150). Tb376M, Tb422M, and M314T were as described(6, 17) .

Degradation Assay

Recombinant DNA constructs produced by PCR as above were used as templates for in vitro transcription by T7 RNA polymerase. RNA was translated in vitro using a rabbit reticulocyte lysate (Promega) in the presence of [S]methionine. The translated proteins were subjected to degradation in a rabbit reticulocyte lysate extract as described(8) . Degradation was carried out at 30 °C, and the labeled protein remaining undegraded was examined by SDS-PAGE and autoradiography(8) . For densitometric analysis of autoradiograms, images were captured and digitized with a Lighttools Research gel documentation system and quantitated with PPLab Gel version 1.5c software. To inhibit degradation, degradation was carried out for 2 h as above, except that 2 mM ATPS was used in place of ATP and the ATP-regenerating system. To test whether the high molecular conjugate of p53 accumulated by ATPS is the polyubiquitinated form of substrate protein, p53 and its conjugate were immunoprecipitated with PAb421 (Oncogene Science) and immunoblotted with ubiquitin antibodies (Sigma).

Association of AZ, ODC, or ODCbulletAZ Complex with the 26 S Proteasome

Mouse ODC, GST, GSTbulletAZ, or GSTbulletODC was transcribed and translated in vitro in the presence of [S]methionine. The in vitro translated GST or GST fusion proteins were directly purified with glutathione-Sepharose 4B. To isolate a complex of ODCbulletAZ, ODC was in vitro translated in the presence of [S]methionine, and GSTbulletAZ fusion proteins were expressed in Escherichia coli. These fusion proteins include AZ amino acids 55-212 (GAZ-55-212) or AZ amino acids 106-212 (GAZ 106-212). These proteins were coupled to glutathione-Sepharose 4B and mixed with the S-labeled in vitro translated ODC. The ODCbulletAZ complexes were eluted from the beads with 20 mM glutathione and mixed with the 26 S protease, the 20 S proteasome, or the 11 S activator, prepared from rabbit reticulocyte lysate(18, 19) . The mixtures were then loaded on non-denaturing gel for electrophoretic separation. The 26 S protease and the 20 S proteasome were identified by the fluorogenic peptide overlay assay (18) and Coomassie Blue staining. The association of ODCbulletAZ complex with the 26 S protease was determined by autoradiography.


RESULTS

Degradation of Mouse ODC Is Induced by NAZ

MODC, like other short-lived proteins, is relatively stable in an in vitro degradation system derived from rabbit reticulocytes(8) . Its degradation is promoted by the addition of the regulatory protein antizyme(8) . Although proteolysis of ODC is maximally stimulated by AZ at a 1:1 stoichiometric ratio, AZ appears to act catalytically, efficiently directing ODC degradation even when the target is present at 100-fold or greater excess(20, 21) . Hence AZ acts catalytically to promote ODC degradation. AZ has two functionally distinguishable regions. The C-terminal half of the protein (CAZ) binds to ODC(7) . The N-terminal part of AZ (NAZ) confers the ability to direct degradation of ODC in vitro or in vivo(7) . To test whether NAZ alone can promote ODC degradation, we fused amino acids 1-97 of antizyme to MODC to make NAZ-MODC (Fig. 1A). As a control, we also fused the C terminus (amino acids 106-212) of antizyme (CAZ) to MODC to make CAZ-MODC. NAZ-MODC was largely degraded in 2 h (Fig. 1B). In contrast, the CAZ-MODC fusion protein was relatively stable. Therefore, NAZ can direct degradation of ODC if it is provided with a means to associate with its target, whether that association is non-covalent as with intact AZ or covalent as in AZ-MODC.


Figure 1: In vitro degradation of MODC induced by fusion to NAZ. The time course of in vitro degradation of [S]methionine-labeled proteins was examined. The labeled proteins remaining undegraded after the indicated period of incubation were examined by SDS-PAGE and autoradiography. A, structure of AZ and fusion proteins. Black bar, NAZ; fine cross-hatched bar, CAZ; coarse cross-hatched bar, MODC. B, MODC fused to the C-terminal half of AZ (CAZbulletMODC) or to the N-terminal half of AZ (NAZbulletMODC) were subjected to degradation for 0, 1, and 2 h. The position of migration of each is indicated by an arrow.



Two Functional Domains Can Jointly Direct Degradation of Trypanosome ODC

Ornithine decarboxylase from T. brucei (TbODC), although almost 70% identical to MODC in its core structure, is a stable protein(9, 22) . It is also insensitive to regulation by polyamines in the native context of the parasite (23) or when expressed in mammalian cells(24) . It lacks both the C-terminal degradation domain and the antizyme-binding domain of mouse ODC. The protein can be converted into one that is unstable in vivo (but still unresponsive to polyamines) by replacing its C terminus with the degradation domain of mouse ODC. This has been done by making chimeric proteins in which a junction between mouse and trypanosome ODC (without insertion or deletion) is created at amino acid 376 (to make Tb376M) (17) or at 422 (to make Tb422M)(8) , as shown in Fig. 2A. Both chimeras were shown to be unstable in vivo by treating cells that expressed the chimeras with an inhibitor of protein synthesis and measuring the rate of decline of ODC activity. However, the Tb376M and Tb422M chimeras, like most other short-lived proteins, were relatively stable in the in vitro degradation assay.


Figure 2: TbODC degradation induced by NAZ and C termini of mouse ODC. A, structure of TbODC and fusions to NAZ and C-terminal regions of MODC (MODC amino acids 376-461 or 422-461). Open bar, TbODC; black bar, NAZ; cross-hatched bar, MODC C termini. B, TbODC, Tb376M, NAZ-TbODC, and NAZ-Tb376M were translated in vitro. The [S]methionine-labeled proteins were subjected to degradation and analyzed as in Fig. 1. C, quantitation of degradation of TbODC, Tb376M, NAZ-TbODC, and NAZ-Tb376M. D, Tb422M and NAZ-Tb422M degradation.



To test whether NAZ was capable of inducing Tb376M degradation in vitro, we coupled NAZ in front of the protein, to make NAZ-Tb376M, as we did for NAZ-MODC (Fig. 2A). In vitro degradation analysis showed that NAZ-Tb376M was degraded (Fig. 2B). Both NAZ and the C terminus of mouse ODC were needed to induce efficient degradation of TbODC; neither Tb376M nor NAZ-TbODC alone was capable of changing the stability of TbODC (Fig. 2B). Densitometric analysis of the data of Fig. 2B is displayed as Fig. 2C. NAZ also stimulated the degradation of Tb422M (Fig. 2D). NAZ-Tb422M contains the entire open reading frame of trypanosome ODC except for the last 2 amino acids, sandwiched between NAZ and the C terminus (amino acids 422-461) of mouse ODC. Therefore, these two functional domains are together necessary and sufficient to cause in vitro degradation of a stable protein, trypanosomal ODC.

We made control fusion proteins consisting of NAZ-TbODC extended at its C terminus by either full-length human papillomavirus 16 E6 (151 amino acids) or the N-terminal 90 amino acids of that protein to determine whether any extension, regardless of sequence specificity, can induce degradation of NAZ-TbODC. Both fusion proteins were subjected to the degradation assay. During the 2-h incubation, the proteins remained undegraded (data not shown). Therefore, the C terminus of mouse ODC must contain a specific functional sequence motif that is able to cooperate with NAZ.

Antizyme-mediated degradation of ODC by the 26 S proteasome is independent of ubiquitination(16) . To examine whether degradation induced by appending NAZ involves ubiquitin modification, we incubated NAZ-Tb376M and NAZ-Tb422M as for in vitro degradation but substituting ATPS in place of ATP. ATPS has been shown to block degradation but not ubiquitination(25) , thereby leading to the accumulation of high molecular weight forms of a target protein decorated by multiple ubiquitin chains. Both NAZ-Tb376M and NAZ-Tb422M were degraded in the presence of ATP (Fig. 3A). Substitution of ATPS for ATP blocked degradation, but high molecular weight conjugates of NAZ-Tb376M and NAZ-Tb422M did not appear. As a positive control, we used HPV16 E6-mediated degradation of p53, which is ubiquitin-dependent. In the presence of E6 and ATP, p53 was degraded (Fig. 3A). When ATPS was used in place of ATP, degradation was blocked and high molecular weight forms of p53 accumulated. Immunoprecipitation with a monoclonal antibody to p53 (PAb421) followed by Western blot analysis using anti-ubiquitin antiserum confirmed that the high molecular weight proteins enhanced in the presence of ATPS consisted of polyubiquitinated p53 (Fig. 3B). Therefore, NAZ-induced degradation, like antizyme-mediated degradation of ODC, is ubiquitin-independent.


Figure 3: Effect of ATPS on degradation of NAZ-Tb376M and NAZ-Tb422M. A, proteolysis was induced by co-incubation of oncoprotein p53 with E6 (left three lanes) or by fusion of NAZ to Tb376M and Tb422M (right six lanes). Samples were analyzed at time 0 or after 2 h of incubation. As indicated, reactions were performed with ATP or replacing ATP with ATPS. B, the composition of conjugates produced as in A was tested by immunoprecipitation with anti-p53 antibody PAb421, separation on SDS-PAGE, and (lanes 1 and 2) autoradiography or (lanes 3 and 4) transfer to nitrocellulose paper and immunodetection with anti-ubiquitin antibody. Lanes 1 and 3, p53 without E6; lanes 2 and 4, p53 incubated with E6 and ATPS. Indicated is the position of high molecular weight ubiquitin conjugates and of IgG heavy chains reactive with the secondary antibody.



The Destruction Box of Cyclin B Can Cooperate with NAZ to Confer Degradation

Sea urchin cyclin B is a well characterized short-lived protein that accumulates at interphase and is degraded at metaphase(26) . Degradation of the protein allows cells to exit metaphase and enter interphase. The protein is stable in frog oocyte extracts prepared from interphase cells, but it is rapidly degraded in metaphase extracts(27) . The specific capacity of mitotic cell extracts to degrade cyclin B thus reproduces faithfully the property of the cell of origin. Degradation of cyclin B requires that it contain both ubiquitination sites and a destruction box(27) . Its N terminus contains all the structural information needed for degradation; the amino acid 13-90 region fused to staphylococcal protein A is able to induce degradation in metaphase cell extracts. A smaller region, amino acids 13-59, does not contain the ubiquitination sites and does not undergo proteolysis, presumably because the lysines within amino acids 60-66 are not present to serve as ubiquitin modification sites. Likewise, a single mutation at the conserved arginine in the destruction box (amino acids 42-50), a conserved region in the N terminus, prevents cycle-specific degradation.

To test whether the cyclin B degradation domain within amino acids 13-90 can confer lability on the otherwise stable TbODC, we fused this region to the C terminus of TbODC (Fig. 4A). As shown in Fig. 4B, the TbODC-cyclin B fusion protein was stable in the reticulocyte lysate. The result agreed with the conclusion that this portion of cyclin alone cannot promote degradation of protein A(27) . However, it became unstable after NAZ was appended to form NAZ-TbODC-cyclin B. Furthermore, deleting the lysine residues that are putative sites of ubiquitination from NAZ-TbODC-cyclin B to form NAZ-TbODC-cyclin B did not alter its degradation. These results suggested that cyclin B amino acids 13-59 contain a degradation domain that can cooperate with NAZ to promote trypanosome ODC degradation in vitro. Furthermore, the degradation is independent of the presence of lysine residues (contained within amino acids 60-90), which are the normal targets for ubiquitination, suggesting that NAZ can provide an alternate signal for degradation that bypasses the requirement for ubiquitin modification.


Figure 4: NAZ-induced degradation of TbODC-cyclin B 13-90 (with ubiquitination site) and TbODC-cyclin B 13-59 (without ubiquitination site). A, structure of Tb-cyclin B 13-90, NAZ-Tb-cyclin B 13-90, and NAZ-Tb-cyclin B 13-59 fusion proteins. The region of cyclin B 13-90-containing lysines that are the ubiquitination sites of cyclin B is marked K. Solid bar, NAZ; open bar, TbODC; hatched bar, cyclin B. B, Tb-cyclin B 13-90, NAZ-Tb-cyclin B 13-90 and NAZ-Tb-cyclin B 13-59 were subjected to degradation and the results analyzed as in Fig. 1.



To test whether NAZ was able directly to induce degradation of the cyclin B degradation region 13-90 in a rabbit reticulocyte lysate, we coupled NAZ in front of either amino acids 13-90 or amino acids 13-59 (Fig. 5A). Both fusion proteins were degraded (Fig. 5B). As expected for a metaphase-specific substrate subjected to degradation in the reticulocyte-based degradation assay system, the cyclin B degradation region 13-90 alone used as a control was relatively stable. NAZ therefore can alter the degradation properties of cyclin B amino acids 13-90 in two ways: promoting its lability in the absence of cycle-specific signals and diverting it to a pathway that does not require ubiquitination.


Figure 5: NAZ-induced degradation of cyclin B 13-90 (with ubiquitination site) and cyclin B 13-59 (without ubiquitination site). A, structure of NAZ-cyclin fusion proteins and unfused cyclin B 13-59 as control. Solid bar, NAZ; hatched bar, cyclin B. B, the proteins were subjected to degradation and the results analyzed as in Fig. 1. C, quantitation of degradation of above fusion proteins, mean of two experiments. (Triangles represent cyclin B 13-90, open circles NAZ-cyclin B 13-90, and solid circles NAZ-cyclin B 13-59.)



Association of ODCbulletAZ Complex with the 26 S Protease Does Not Require NAZ

To determine whether NAZ is needed for the association of ODCbulletAZ with the 26 S protease, we prepared two forms of antizyme to complex with ODC, AZ amino acids 55-212 and AZ amino acids 106-212. We have shown that the larger of the two truncated proteins can induce ODC degradation in vitro, but the smaller one cannot(7) . However, both efficiently form a complex with ODC. [S]Methionine-labeled mouse ODC was made by in vitro translation and allowed to associate with purified GST recombinant fusion proteins GAZ 55-212 or GAZ 106-212. The ODCbulletAZ complexes were mixed with the 26 S protease or with 20 S proteasome or with 11 S activator (18, 19) and fractionated by non-denaturing gel electrophoresis. The positions on the gel of 20 S proteasome, 26 S protease, or 11 S activator were visualized by Coomassie Blue staining or by an overlay assay with a fluorogenic peptide(18, 19) . Association of ODCbulletGAZ 55-212 with the 26 S protease was observed (Fig. 6). The complex did not bind to the 20 S proteasome, in agreement with a previous report that ODCbulletAZ was degraded by the 26 S protease, not the 20 S proteasome (16) . There was no association of the complex with the 11 S activator. The complex of ODCbulletGAZ 106-212, which lacks NAZ, was able to bind the 26 S protease as well as ODCbulletGAZ 55-212. This result demonstrates that NAZ is not required, under the conditions of this assay, for the association between substrate and proteolytic machine.


Figure 6: Association of ODCbulletAZ complex with the 26 S protease. Mouse ODC was in vitro translated in the presence of [S]methionine and affinity-purified on a matrix consisting of fusion proteins GAZ 55-212 or 106-212 affixed to glutathione-Sepharose 4B beads. The complexes ODCbulletGAZ 55-212 and ODCbullet106-212 were eluted with glutathione and mixed with 26 S protease, 20 S proteasome, or 11 S activator. The mixture was then subjected to non-denaturing gel electrophoresis. The 26 S protease and 20 S proteasome were identified by the fluorogenic peptide overlay assay (not shown) and by Coomassie Blue staining (A). B, the complexes were mixed with 26 S protease, 20 S proteasome, or 11 S activator as indicated, and the ODCbulletAZ complex was visualized by autoradiography.



To test whether each component of the ODCbulletAZ complex can separately associate with the 26 S proteasome, we produced [S]methionine-labeled ODC and AZ as GST fusion proteins by in vitro translation. The fusion proteins, purified by affinity chromatography with glutathione-Sepharose 4B, were mixed with 20 S proteasome or 26 S protease for the association assay. GSTbulletODC and GSTbulletAZ fusion proteins were each able to associate with the 26 S protease but not the 20 S proteasome (Fig. 7A). GST alone was unable to associate with either of the proteases. Next, to test whether NAZ is necessary for the association of AZ with 26 S, we analyzed both forms of AZ, GSTbulletAZ 55-212 and GSTbulletAZ 106-212. We found that both truncated proteins were able to associate with the 26 S protease, again indicating that NAZ is not required for association (Fig. 7B). Therefore, NAZ must serve some other function in the destruction of ODC.


Figure 7: Association of ODC and AZ with 26 S protease. Constructs encoding GST or fusions of GST to AZ or to MODC were translated in vitro in the presence of [S]methionine and purified with glutathione-Sepharose 4B beads. The purified proteins were eluted and mixed with a preparation of 20 S proteasomes or the 26 S protease. The mixtures were then loaded on non-denaturing gel for electrophoresis separation. Associated ODC or AZ was determined as in Fig. 6. A, association of GST, GSTbulletMODC, or GSTbulletAZ with 20 S proteasome and 26 S protease. B, association of GAZ 55-212 or GAZ 106-212 with 26 S protease. C, association of GST, GSTbulletMODC, GSTbulletM314T, and GSTbulletTbODC with 26 S protease.



Finally, we examined the capacity of trypanosome ODC (TbODC) to associate with proteasomes. Using a GSTbulletTbODC fusion protein, we found that TbODC, unlike MODC, did not associate with the 26 S protease. To find out whether the C terminus of MODC, required for protein instability, is also necessary for MODC association with 26 S, we made a GSTbulletM314T fusion chimera, containing the N terminus of MODC and the C terminus of TbODC, with the junction at amino acid 314. This GSTbulletM314T chimera was able to associate with the 26 S protease (Fig. 7C). This result suggests that the difference between TbODC and MODC in their ability to associate with the 26 S protease does not depend on the C terminus of mouse ODC but rather on sequence information contained within its first 314 amino acids.


DISCUSSION

Vertebrate ODC is a labile protein with a half-life in cells of less than an hour(28) . C-terminal deletions or mutations can make it stable, and the C terminus appended to other proteins can confer on these a short half-life(17, 24) . The C terminus is therefore both necessary and sufficient to provide a moderate degree of lability. ODC becomes still more labile in the presence of AZ(28) . The AZ binding site within ODC is near its N terminus. Mutations in that binding site destroy the regulatory effect of AZ on ODC activity and abolish the regulatory effect of polyamines on ODC in cells. The AZbulletODC complex is an efficient substrate for in vitro degradation. Normally, AZ binds to ODC and is not itself consumed as rapidly as ODC but acts catalytically to mediate ODC degradation(20, 21) . We have shown here, by directly coupling it to ODC, that the N terminus of AZ is solely responsible for its degradative role. The fusion construct NAZbulletMODC contains the two domains needed for degradation, the AZ N terminus and the mouse ODC C terminus. These are enough to destabilize the otherwise stable protein trypanosome ODC. This finding has encouraged us to use NAZ fusions as a general means to identify and analyze degradation domains of other proteins uncoupled from earlier steps in the degradation process(29) .

NAZ could act either as a bridge to bring together substrate ODC and 26 S protease or as a protease activator. Our results are inconsistent with the first possibility; the 26 S protease associates with ODCbulletAZ independently of the presence of NAZ. In fact, each protein alone can associate with the protease, and this recognition process is dependent on neither the N terminus of AZ nor the C terminus of mouse ODC. It is therefore improbable that these degradative elements serve as recognition signals.

Regulatory proteins, such as cyclins and oncoproteins, are usually short-lived in cells. Understanding the signals that direct their degradation is facilitated by mutagenesis and in vitro analysis of those signals. It may be difficult, however, to interpret the results of such experiments with proteins that require ubiquitination for turnover. Mutations of target proteins that interfere with degradation could do so by inhibiting ubiquitination or, alternatively, by impeding downstream steps. One can bypass the need for ubiquitination and thus simplify analysis by attaching a protein element that provides a functional alternative to ubiquitination to target proteins. NAZ has these properties. Its presence drives proteins down a proteasome-mediated degradation pathway with downstream elements common to ubiquitinated and non-ubiquitinated targets, thus bypassing the need for that modification. Furthermore, the NAZ domain is effective in promoting in vitro degradation. By conferring in vitro lability on natural substrates of in vivo degradation, it can be used to assist the analysis of cis-acting structural determinants of degradation. We here applied this form of analysis to establish that a region of cyclin B containing the destruction box acts as a degradation domain that can function independently of ubiquitin. This was further confirmed by demonstrating that the degradation domain of cyclin can effectively replace of the C-terminal degradation domain of mouse ODC.

Most short-lived proteins require polyubiquitination to be degraded. The exact role of ubiquitination in proteolysis is not well understood. It has been proposed that the modification is a direct recognition signal for the protease complex. Recently a specific protease subunit has been identified as the locus of interaction with polyubiquitin (30) . A degradation domain could act as a proteolysis site, which is made available for digestion by ubiquitin modification, or a site of association with other proteins required for proteolysis, e.g. a chaperone. The work described here supports the hypothesis that NAZ shares with polyubiquitination the need for collaboration with a degradation domain. Because NAZ can function as an independent module when appended to diverse proteins, it can be used as an analytic reagent for probing the structure of degradation domains. This method of analysis is applied to the tumor suppressor p53 in the accompanying paper(29) .


FOOTNOTES

*
This work was supported by National Institutes of Health Grant RO1 GM45335 (to P. C.), National Institutes of Health Grant RO1 GM37009 (to M. R.), National Cancer Institute Grant CA 09043 (which provided support for X. L.), and by a generous gift from the Lucille Markey Charitable Trust (to M. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

(^1)
The abbreviations used are: ODC, ornithine decarboxylase; NAZ, N terminus of antizyme; AZ, antizyme; PCR, polymerase chain reaction; MODC, mouse ODC; TbODC, T. brucei ODC; CAZ, C-terminal half of antizyme; PAGE, polyacrylamide gel electrophoresis; ATPS, adenosine 5`-O-(thiotriphosphate); GST, glutathione S-transferase.


REFERENCES

  1. Fong, W. F., Heller, J. S., and Canellakis, E. S. (1976) Biochim. Biophys. Acta 428, 456-465 [Medline] [Order article via Infotrieve]
  2. Heller, J. S., Fang, W. F., and Canellakis, E. S. (1976) Proc. Natl. Acad. Sci. U. S. A. 73, 1858-1862 [Abstract]
  3. Kitani, T., and Fujisawa, H. (1984) J. Biol. Chem. 259, 10036-10040 [Abstract/Free Full Text]
  4. Matsufuji, S., Miyazaki, Y., Kanamoto, R., Kameji, T., Murakami, Y., Baby, T. G., Fujita, Ohno, T. K., and Hayashi, S. (1990) J. Biochem. (Tokyo) 108, 365-371
  5. Miyazaki, Y., Matsufuji, S., and Hayashi, S. (1992) Gene (Amst.) 113, 191-197
  6. Li, X., and Coffino, P. (1992) Mol. Cell. Biol. 12, 3556-3562 [Abstract]
  7. Li, X., and Coffino, P. (1994) Mol. Cell. Biol. 14, 87-92 [Abstract]
  8. Li, X., and Coffino, P. (1993) Mol. Cell. Biol. 13, 2377-2383 [Abstract]
  9. Ghoda, L., van Daalen Wetters, T., Macrae, M., Ascherman, D., and Coffino, P. (1989) Science 243, 1493-1495 [Medline] [Order article via Infotrieve]
  10. Goldberg, A. L., and Rock, K. L. (1992) Nature 357, 375-379 [CrossRef][Medline] [Order article via Infotrieve]
  11. Gottesman, S., and Maurizi, M. R. (1992) Microbiol. Rev. 56, 592-621 [Abstract]
  12. Hershko, A., and Ciechanover, A. (1992) Annu. Rev. Biochem. 61, 761-807 [CrossRef][Medline] [Order article via Infotrieve]
  13. Rechsteiner, M., Hoffman, L., and Dubiel, W. (1993) J. Biol. Chem. 268, 6065-6068 [Free Full Text]
  14. Glass, J. R., and Gerner, E. W. (1987) J. Cell. Physiol. 130, 133-141 [Medline] [Order article via Infotrieve]
  15. Bercovich, Z., Rosenberg-Hasson, Y., Ciechanover, A., and Kahana, C. (1989) J. Biol. Chem. 264, 15949-15952 [Abstract/Free Full Text]
  16. Murakami, Y., Matsufuji, S., Kameji, T., Hayashi, S., Igarashi, K., Tamura, T., Tanaka, K., and Ichihara, A. (1992) Nature 360, 597-599 [CrossRef][Medline] [Order article via Infotrieve]
  17. Ghoda, L. Y., Phillips, M. A., Bass, K. E., Wang, C. C., and Coffino, P. (1990) J. Biol. Chem. 265, 11823-11826 [Abstract/Free Full Text]
  18. Hoffman, L., Pratt, G., and Rechsteiner, M. (1992) J. Biol. Chem. 267, 22362-22368 [Abstract/Free Full Text]
  19. Dubiel, W., Pratt, G., Ferrell, K., and Rechsteiner, M. (1992) J. Biol. Chem. 267, 22369-22377 [Abstract/Free Full Text]
  20. Murakami, Y., Tanaka, K., Matsufuji, S., Miyazaki, Y., and Hayashi, S. (1992) Biochem. J. 283, 661-664 [Medline] [Order article via Infotrieve]
  21. Mamroud-Kidron, E., Omer-Itsicovich, M., Bercovich, Z., Tobias, K. E., Rom, E., and Kahana, C. (1994) Eur. J. Biochem. 226, 547-554 [Abstract]
  22. Phillips, M. A., Coffino, P., and Wang, C. C. (1987) J. Biol. Chem. 262, 8721-8727 [Abstract/Free Full Text]
  23. Bass, K. E., Sommer, J. M., Cheng, Q. L., and Wang, C. C. (1992) J. Biol. Chem. 267, 11034-11037 [Abstract/Free Full Text]
  24. Ghoda, L., Sidney, D., Macrae, M., and Coffino, P. (1992) Mol. Cell. Biol. 12, 2178-2185 [Abstract]
  25. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. (1990) Cell 63, 1129-1136 [Medline] [Order article via Infotrieve]
  26. Evans, T., Rosenthal, E. T., Youngblom, J., Distel, D., and Hunt, T. (1983) Cell 33, 389-396 [Medline] [Order article via Infotrieve]
  27. Glotzer, M., Murray, A. M., and Kirschner, M. W. (1991) Nature 349, 132-138 [CrossRef][Medline] [Order article via Infotrieve]
  28. Murakami, Y., and Hayashi, S. (1985) Biochem. J. 226, 893-896 [Medline] [Order article via Infotrieve]
  29. Li, X., and Coffino, P. (1996) J. Biol. Chem. 271, 4447-4451 [Abstract/Free Full Text]
  30. Deveraux, Q., Ustrell, V., Pickart, C., and Rechsteiner, M. (1994) J. Biol. Chem. 269, 7059-7061 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.